Abstract: A cremation urn comprising an internal structure with an opening, an external opening with an opening that is correspondingly aligned with the opening on the internal structure, and sealing means in the form of a threaded lid or press fit lid. A threaded flange is attached to the opening on the internal structure and is molded into the urn during manufacturing. The materials used for the urn produce an urn with the appearance of marble. Once the urn is made, by use of a manufacturing method, the threaded lid is screwed into the threaded flange, thereby creating a one-piece, air-tight and water-tight cremation urn.

Abstract: A compartmentalized cremation urn and system for retaining multigenerational cremains of humans and/or pets is provided. The multigenerational cremation urn may store multigenerational cremains in a single compartmentalized container as well as showcase images of the deceased. A removable lid is provided. The lid in a closed condition over the compartmentalized container may highlight a view area of the cremains. An image carousel may be provided on the top of the lid. The image carousel may provide a plurality of radially extending display frames for housing images capturing the memories of those inurned in the multigenerational cremation, wherein a user may selectively rotate the image carousel for viewing a lineage of loved ones of humans and/or pets across multiple generations.

Abstract: A three-dimensional spine correction robot includes: a pillar, a seat, human body fixing belts, a head fixing apparatus, a bracket, pillar casing pipes, a spine lateral push-and-pull apparatus and a seat locking mechanism. The head fixing apparatus is fixed on the top of the bracket. The pillar casing pipes are movably sleeved over the pillar, and each pillar casing pipe is connected to a human body fixing belt. The lower end of the pillar casing pipe is connected to the seat, and the upper end is connected to the pillar. A first elastic connection object is connected between the pillar casing pipes. The spine lateral push-and-pull apparatus may move up and down along the pillar and swing. The seat is connected to the pillar through a bearing, and may move up and down along the pillar. The seat locking mechanism is fixed between the bracket and the seat.

Abstract: Exoskeleton technology is described herein. Such technology includes but is not limited to exoskeletons, exoskeleton controllers, methods for controlling an exoskeleton, and combinations thereof. The exoskeleton technology may facilitate, enhance, and/or supplant the natural mobility of a user via a combination of sensor elements, processing/control elements, and actuating elements. User movement may be elicited by electrical stimulation of the user's muscles, actuation of one or more mechanical components, or a combination thereof. In some embodiments, the exoskeleton technology may adjust in response to measured inputs, such as motions or electrical signals produced by a user. In this way, the exoskeleton technology may interpret known inputs and learn new inputs, which may lead to a more seamless user experience.

Abstract: An exercise device for stretching the calf muscles and Achilles tendon of a user. The exercise device includes a rod with a pair of grips, a pair of straps, and a foot platform. The pair of straps has two ends; or a first end and a second end. The first end of each strap is affixed to opposing distal ends of the rod. The second end of the pair of straps is affixed to distal, or outside, ends of the foot platform. The exercise device can have a rotatable sleeve with a plurality of surface protuberances on the sleeve. The rotatable sleeve is mounted on the rod between the pair of grips. The rotatable sleeve can be used as a massager by rolling the sleeve over a muscle while gripping the grips on either side of the sleeve.

Abstract: The proposed method is intended for rhythmic stimulation of neurotrophic reflexes to simultaneous stretching of muscles in various sections of spine, joints of limbs and in the main muscles of a human body. The aforesaid method can be implemented by employing an exercise machine that provides for mechanical anti-phase oscillations of lodgments affecting various sections of the body and limbs without considerable movements of the neck-and-head lodgment in the vertical direction. The upper body and the lower limbs make in-phase reciprocal movements, while the pelvic area makes movements anti-phase relative thereto. A support for the neck-and-head part is installed to allow supporting natural movements of the head in the course of the aforesaid movements of the upper body. The design of the exercise machine is described in detail herein.

Abstract: A rolling walker comprises a frame, a seat supported by that frame, and a backrest supported by the frame. By one approach the backrest is configured to selectively move between a first position that provides back support for a person sitting in the seat facing in a forward direction and a second position that provides back support for a person sitting in the seat facing in a rearward direction. If desired, this backrest can be comprised of a material (such as a memory foam material) that biases the backrest towards that first position when the backrest is in the first position and that biases the backrest towards the second position when the backrest is in the second position.

Abstract: This invention pertains to advanced medical walker that provides tremendous safety to the users of the medical walker. The novelty introduced here is the addition of the foldable seat pads and safety legs to the medical walker to protect the user from falling down in an uncontrollable situation or fatigue condition, wherein falling down and its resulting traumatic injuries is a serious concern for the users who are in the low-energy state, or are without the accompany of a caring attendance. This invention addresses this concern. There is a wide variety of operation for this invention; this walker can be used in any private or public place such as private homes, hospitals, nursing homes, medical care centers, and alike.

Abstract: A therapeutic mat is described. The mat provides therapeutic relief in the form of vibratory motion and/or heat. The mat or pad is particularly useful as a floor mat in a vehicle. The mat includes provisions to enable powering the mat from a 12-volt direct current source, such as used in an automobile or other vehicle. A massage module can be removed from the mat to facilitate cleaning of the mat. The mat may also include one or more upwardly extending provisions for massaging the arch region of a user's feet. Also described are illuminated mats. The lights of a mat can operate based upon the operation of another mat, pulsations of the massage module, or based upon acoustic levels in the vehicle.

Abstract: An electronic vibrating compression glove which simultaneously provides compression and vibration therapy to arthritic hands.

Abstract: A device for stimulating the Meissner's Corpuscles along the front plantar portion of the foot or feet of a person is provided. The device has a platform disposed upon motion guides for movement up and down with respect to a base. The platform has a shaped surface for ease of placement of at least the front plantar portion of at least one foot of a person seated in front of the device in which the back or heel portion of the foot is disposed away from the device. One or more inertial actuators are attached to the platform underneath its surface. A controller controls operation of the actuator(s), via signals to a driver, to move the platform with respect to the base in a sinusoidally varying motion at a user selectable stimulation level. The stimulation level may be set wirelessly via an external device, or by manually tilting the device.

Abstract: An apparatus for reanimation of a patient that includes a plunger driven by a drive to perform a compressive massage on the patient's body, a position measuring device that measures the respective position of the plunger during its compressive massaging motion, and a holding device for the drive and the plunger.

Abstract: A whirlpool bathtub system includes a basin having a plurality of nozzles, a water feed line connected to the plurality of nozzles, an air feed line connected to the plurality of nozzles, a pump configured to circulate water to the basin through the water feed line, and a blower having an off condition and an on condition, the blower being configured to provide air to the basin through the air feed line. When the blower is in the off condition, the blower is configured to allow air to flow into the air feed line. When the blower is in the on condition, the blower is configured to increase the flow of air flowing into the air feed line.

Abstract: A control panel for an enclosed space, set into a cutout in the wall of the enclosed space, that can rotate at least 180 degrees so as to be accessible from either the inside or the outside of the enclosed space.

Abstract: Embodiments of dermatological cell treatment are described generally herein. Other embodiments may be described and claimed.

Abstract: Coated pharmaceutical packages are disclosed. In embodiments, a coated pharmaceutical package includes a glass body comprising a first surface. A low-friction coating may be positioned on at least a portion of the first surface of the glass body. The low-friction coating may include a polymer chemical composition. A light transmission through the coated pharmaceutical package may be greater than or equal to about 55% of a light transmission through an uncoated pharmaceutical package for wavelengths from about 400 nm to about 700 nm. The low-friction coating may have a mass loss of less than about 5% of its mass when heated from a temperature of 150° C. to 350° C. at a ramp rate of about 10° C./minute.

Abstract: To provide a medication storage cell that can be easily opened by a person who cannot dexterously move his or her fingertips. A small-medication storage cell (12) is provided with an accommodating section (20) and an interlocking piece (22). The accommodating section (20) has an outlet for a medication (100). The outlet (30) is formed using a sheet (60) provided with an interlocking piece, and a cover sheet (62). The interlocking piece (22) has a base section (40) and a tip end section (42). At least a part of the base section (40) is separated from the surface of the accommodating section (20). The tip end section (42) is fastened to the accommodating section (20) in a bent state so that the cover sheet (62) and the sheet (60) provided with an interlocking piece close the outlet (30).

Abstract: The present invention relates to a barrier membrane arrangement (10, 110) for a medical device for providing a substantially liquid tight seal between a piercing member and a barrier member (12) and a method for manufacturing such a barrier member arrangement. The present invention also relates to a method for connecting a first and a second medical device at the barrier member arrangement (10, 110). The barrier member arrangement (10, 110) comprises a first member (11), a second member (13) and a barrier member (12). The second member (13) can be interlocked to the first member (11) by means of a connection arrangement (18) at an optional stage by a user. After interlocking the second member (13) to the first member (11), the barrier member (12) has been compressed to provide for an increased leakage security. The barrier member arrangement (10, 110) also provides for a prolonged working life of the barrier member (12) and any medical device which comprises such a barrier member arrangement (10, 110).

Abstract: An integrated medicine mixing interface comprising a medicine mixing mouth (1), hard double interfaces (2) and a medicine feed needle (3). The hard double interfaces (2) comprise a base (21), a medicine mixing interface (22) and an infusion interface (23). The medicine mixing mouth (1) and the medicine mixing interface (22) are integrated. When using the integrated medicine mixing interface, it is only necessary to weld the base (21) to the bag body of a soft infusion bag (11) and integrate the medicine mixing mouth (1) with the medicine mixing interface on the hard double interfaces (2) without adopting a hose connection and an easily folding handle, which not only reduces hose installation location, but also avoids welding leakage brought about by hose welding defects. Moreover, the structure is simple and the costs are low.

Abstract: Described herein is a 3-dimensional interchangeable icon bottle cap assembly, or cap with textured indicia, with top plates that interface with prescription bottle caps using icons, graphics and colors that help patients understand when to take their medication, what the medication is for, and provide the ability to keep track of medication compliance.

Abstract: Various embodiments relate to systems and methods for monitoring adherence to a medication regimen through the use of a smart medication container. The container can include an electronic display that presents relevant information, such as dosage and/or medication information, instructions, user information, messages, notifications, and device information (e.g., battery status, network connectivity status). A pair of conductive elements positioned on either side of the container's opening can be configured to continually measure capacitance in order to identify when contents (e.g., pills) leave the container. More than one pair of conductive elements may be used to improve accuracy and reduce the effects of noise. A processor is able to analyze the capacitance data and determine whether medication has been dispensed from the container and, if so, how much medication was dispensed. A computer system can then compare the results to a planned medication regimen to determine a state of compliance.

Abstract: A device and method for enterally hydrating a patient with cooled fluids. The patient may be a paralyzed or limited upper body mobility patient with a functional gastrointestinal system who is nonetheless incapable or not fully capable of drinking unassisted. Here fluids are provided by a suspended container which also has a pouch to admit cooling material such as ice, but to keep the cooling material separate from the fluid. The container may also have optional graduation markings to allow for convenient estimation of fluid use, and an upper open and closeable cap to allow the container to be refilled. The container has a lower fluid conducting tube that terminates in a mouthpiece. The mouthpiece contains a fluid valve formed from at least one slit in an elastic material. Patient mouth force on the valve causes the slit to enlarge, thus enabling cooled fluid to flow into the patient.

Abstract: A feeding tube and method for introducing a feeding tube within the gastrointestinal tract of a patient, whereby the feeding tube is introduced by using a variation of the Ponsky “pull” method of feeding tube placement. The feeding tube comprises an elongate shaft having a distal end and proximal end. The feeding tube also comprises a coupling structure for coupling the feeding tube to a pull wire, the coupling structure being internal to and proximal of the distal end of the feeding tube shaft. The coupling structure is configured to engage an outwardly biased anchor member affixed to the end of the pull wire. The feeding tube is introduced within the patient by attaching the anchor member of the previously placed pull wire to the coupling structure of the feeding tube, and then pulling the pull wire so as to pull the feeding tube into and through the gastrointestinal tract of the patient.

Abstract: Nutritional formulas comprising long-chain polyunsaturated fatty acids (LC-PUFAs) are provided, along with methods and devices for preparing and/or administering nutritional formulas. In some embodiments, a percentage of the LC-PUFAs in the nutritional formula are in the form of monoglycerides and/or free fatty acids. In some embodiments, the nutritional formulas do not comprise added lipase. Also provided are methods for providing nutrition to a subject, methods for improving fat absorption, methods for improving cognitive ability, methods for preventing chronic lung disease, and methods for reducing the length of time a patient requires total parenteral nutrition.

Abstract: Nutritional formulas comprising long-chain polyunsaturated fatty acids (LC-PUFAs) are provided, along with methods and devices for preparing and/or administering nutritional formulas. In some embodiments, a percentage of the LC-PUFAs in the nutritional formula are in the form of monoglycerides and/or free fatty acids. In some embodiments, the nutritional formulas do not comprise added lipase. Also provided are methods for providing nutrition to a subject, methods for improving fat absorption, methods for improving cognitive ability, methods for preventing chronic lung disease, and methods for reducing the length of time a patient requires total parenteral nutrition.

Abstract: According to the invention, gene products expressed in a tumor-associated manner and the nucleic acids coding therefor were identified. The invention relates to the therapy and diagnosis of diseases wherein said gene products expressed in a tumor-associated manner are aberrantly expressed. The invention also relates to proteins, polypeptides and peptides which are expressed in a tumor associated manner and to nucleic acids coding therefor.

Abstract: A one-part self-etching, self-priming dental adhesive having a pH of at most 2, which comprises an aqueous mixture containing (i) one or more polymerizable monomers optionally containing an acidic group, (ii) optionally one or more organic or inorganic acids, (iii) a polymerization initiator, and (iv) a thermal polymerisation inhibitor of the following formula (I): ?wherein R?1 represents a hydrogen atom, or a saturated hydrocarbon group having 1 to 18 carbon atoms. R?2, which may be the same or different if more than one R?2 is present, independently represent a saturated hydrocarbon group having 1 to 18 carbon atoms, and c represents an integer of from 1 to 4.

Abstract: It is one of the objects of the present disclosure to provide hexagonal prism-shaped zinc oxide particles having improved ultraviolet shielding ratio at the wavelength of 400 nm or less without impairing the direct transition properties of electronic excitation thereof and having remarkably improved ultraviolet shielding ratio for UV-B radiation and UV-A radiation; and a zinc oxide particle containing a solid solution of a Ti element and/or a Fe element and a Zn element in at least a portion thereof, and having a hexagonal prism shape.

Abstract: The invention provides an orally acceptable plaque indicator gel comprising a dye in sufficient concentration to visibly stain plaque upon application, optionally for use in combination with an orally acceptable plaque removal gel comprising an antiplaque agent in sufficient concentration to remove plaque and or kill bacteria upon application, in each case the gel having a specific viscosity permitting efficient application using a pen dispenser, as well as reduced dye or antiplaque agent concentration, together with methods of using the same.

Abstract: Liposomal topical compositions containing phenolic anti-inflammatory agents, and methods for making thereof, are presented. These compositions are generally used for helping to prevent solar radiation-induced skin damage and helping to prevent and/or treat inflammatory dry skin conditions caused by eczema and contact dermatitis.

Abstract: A tooth whitening method applies a light transmitting oxidizing composition to teeth in an oral cavity, after which a hand-held LED light source with a light transmitting lens and a cup forming a chamber having an open end is moved over the teeth so that the cup distributes the oxidizing composition while the teeth are exposed to light transmitted through the lens. This not only ensures intimate contact of the teeth with the oxidizing composition, but also maintains a more or less constant spacing between the light source and the tooth surfaces for optimum results. A sealant is then applied to the teeth to resist moisture contamination of the oxidizing composition.

Abstract: A UHT process for the manufacture of an aqueous antiperspirant composition comprising the steps of: (i) mixing aluminium-containing antiperspirant salt, water soluble calcium salt, amino acid, and water, (ii) heating the mixture to a temperature of greater than 100° C. at a pressure of greater than 1 Bar (100,000 Pa) and (iii) restoring the mixture to ambient temperature and pressure.

Abstract: Described herein are oral care compositions comprising a tetrabasic zinc halide and an amino acid; along with methods of making and using the same.

Abstract: A personal care composition is provided having a highly volatile fragrance which incorporates alpha pinene, beta pinene, hexyl acetate, limonene, (+)-citronellal, dihydromyrcenol, alpha citronellol, beta citronellol, genaniol, lilial or combinations thereof in conjunction with tricyclodecane amide. The tricyclodecane amide functions to prevent fast volatilization of the highly volatile fragrance components when the personal care composition is applied to skin or hair of the human body.

Abstract: Disclosed the use of gelatin or deeply processed gelatin materials in the preparation of hair quality-improving compositions.

Abstract: The present invention concerns the use of a specific copolymer to homogenize compositions that include coloring pigments and/or pearlescent pigments and film-forming polymers, as well as the cosmetic compositions containing said copolymer.

Abstract: A skin composition includes between 5% and 95% of polyethylene glycol and between 5% and 95% of glycereth. The composition is a gel that is formulated for application to an individual's skin.

Abstract: The present invention relates to a personal care composition for topical application having skin lightening application. It is an object of the present invention to provide for a personal care composition that comprises fractions obtained from natural sources that gives enhanced skin lightening as compared to known fractions from natural sources.

Abstract: Compositions comprising electro-activated aqueous solutions and methods for the prevention and treatment of dysfunctional cardiovascular conditions are provided.

Abstract: Disclosed is a microneedle coating composition comprising a physiologically active substance (excluding Japanese encephalitis vaccine antigen), a basic amino acid, and an acid, wherein the mole number of the acid for one mole of the basic amino acid is larger than 1/(N+1) and less than 2, where N represents the valence of the acid.

Abstract: Effective treatments of pain that accompanies post-operative surgeries are provided. Through the administration of an effective amount of a combination of bupivacaine and clonidine at or near a target site, one can alleviate or prevent pain. This administration of bupivacaine and clonidine or pharmaceutically acceptable salts thereof is particularly useful following surgery.

Abstract: A drink for moderating blood glucose levels produced by a meal in a human subject suffering diabetes or impaired glucose tolerance (IGT) the drink comprising: at least one water soluble or water dispersible compound selected from the group consisting of amino acids, peptides and proteins in a total amount of at least 8g on a dry weight basis per serving of drink; aqueous liquid in an amount of from 70 ml to 400 ml (preferably in an amount of from 100 ml to 250 ml and more preferably from 125 ml to 175 ml) per serving, and wherein the drink exhibits shear banding when subject to the shear banding test herein described.

Abstract: A process for producing a pharmaceutical suspension that comprises an active pharmaceutical ingredient (“API”) having low solubility, the process comprises: (a) preparing a first solution comprising a carboxy-containing vinyl polymer and a solvent; and (b) adding a compound of the API to said first solution under conditions of high-shear mixing for a time from about 5 minutes to about 5 hours, said compound being soluble in said solvent, thereby producing a suspension of particles of said API in a composition comprising said carboxy-containing vinyl polymer; wherein a concentration of said API in said suspension is higher than a solubility of said API in said solvent. The present invention also provides a suspension produced by such process.

Abstract: A liposome including an elastin-like polypeptide (ELP) and a tumor cell targeting material, a pharmaceutical composition including the liposome, and a method of delivering an active agent to a target site using the liposome.

Abstract: The specification relates to an internal structured self assembled liposome (ISSAL), containing a nuclear core molecule or complex including a first affinity enhancing molecule; and a phospholipid-affinity enhancing complex having a phospholipid coupled to second affinity enhancing molecule, wherein the second affinity enhancing molecule couples to the first affinity enhancing molecule. The ISSAL's can be used in, for example and without limitation, the field of drug delivery, vaccination, imaging contrast agents, and nanotechnology, in which liposomes of ordered, self-assembling structure are employed to deliver soluble or insoluble molecules to any sub-cellular address.

Abstract: A biosensor system determines analyte concentration from an output signal generated from a light-identifiable species or a redox reaction of the analyte. The biosensor system compensates at least 50% of the total error in the output signal with a primary function and may compensate a portion of the residual error with at least one residual function. A segmented signal processing (SSP) function may serve as the primary function, first residual function, or second residual function. Preferably, when the SSP function serves as the first residual function, the SSP function compensates at least 50% of the residual error remaining after primary compensation. Preferably, when the SSP function serves as the second residual function, the SSP function compensates at least 50% of the residual error remaining after primary and first residual compensation. The error compensation provided by the primary, first residual, and second residual functions may be adjusted with function weighing coefficients.

Abstract: The invention relates to solid medicinal forms containing at least one active ingredient and at least one pharmaceutically compatible, water soluble drying agent which is selected from the group consisting of trimagnesium dicitrate and/or calcium chloride, the solid medicinal form having a drying loss of at most 6% and a relative equilibrium moisture content of 25% or less. The invention also relates to solid medicinal forms containing a moisture-sensitive active ingredient and trimagnesium dicitrate.

Abstract: The present invention relates to pharmaceutical dosage forms, for example to a tamper resistant dosage form including an opioid analgesic, and processes of manufacture, uses, and methods of treatment thereof.

Abstract: The present invention relates to pharmaceutical dosage forms, for example to a tamper resistant dosage form including an opioid analgesic, and processes of manufacture, uses, and methods of treatment thereof.

Abstract: The present invention relates to pharmaceutical dosage forms, for example to a tamper resistant dosage form including an opioid analgesic, and processes of manufacture, uses, and methods of treatment thereof.